Drug delivery for metabolism targeted cancer immunotherapy
- 31 March 2022
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 184, 114242
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 148 references indexed in Scilit:
- Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor functionJournal of Clinical Investigation, 2013
- Tumor glycolysis as a target for cancer therapy: progress and prospectsMolecular Cancer, 2013
- Cancer Cell Metabolism: One Hallmark, Many FacesCancer Discovery, 2012
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cellsJournal of Experimental Medicine, 2011
- Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12Journal of Immunotherapy, 2010
- Glutamine addiction: a new therapeutic target in cancerTrends in Biochemical Sciences, 2010
- Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cellsBritish Journal of Cancer, 2010
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex IIOncogene, 2008